Las Vegas, NV -- (SBWIRE) -- 10/08/2013 -- Beststocksondemand.com, is a financial newsletter and blog focused on shedding light on under-discovered small cap companies. Our team of professionals from various backgrounds work diligently to bring our members the best penny stock picks, stock market commentary, and news on all types of OTCBB and Pink Sheet companies, Recon Technology, Ltd. (NASDAQ:RCON), CARDIOME PHARMA CORP (NASDAQ:CRME), Cell Therapeutics Inc (NASDAQ:CTIC), Chinanet Online Holdings Inc (NASDAQ:CNET)
Recon Technology, Ltd. (NASDAQ:RCON) opened the session at $2.41, remained amid the day range of $2.41 - $3.13, and closed the session at $2.99. The stock showed a positive performance of 25.06% in previous trading session. The stock gained a volume of 787,616 shares and the average volume of the stock remained 59,280 shares. Recon Technology, Ltd is a limited liability company. The Company provides hardware, software, and on-site services to companies in the petroleum mining and extraction industry in People's Republic of China. It provides services designed to automate and enhance the extraction of petroleum. It controls by contract the PRC companies of Beijing BHD Petroleum Technology Co., Ltd., Nanjing Recon Technology Co., Ltd. and Jining ENI Energy Technology Co., Ltd. (collectively, the Domestic Companies).
Why Should Investors Buy CLWR After The Recent Gain? Just Go Here and Find Out
CARDIOME PHARMA CORP (NASDAQ:CRME) traded with volume of 1.25 million shares in the prior session and the average volume of the stock remained 153,472 shares. The 52 week range of the stock remained $1.20 - $5.35. The stock showed a positive movement of 24.88% and closed its session at $5.12. The market capitalization of the stock remained 63.85 million. Cardiome Pharma Corp. (Cardiome) is a research-based biopharmaceutical company. The Company is focused on the discovery, development and commercialization of new therapies. It has one product, BRINAVESS, approved for marketing in Europe and other territories for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults.
What was the Moving Force behind CRME on Bullish Run? Read This Research Report
Cell Therapeutics Inc (NASDAQ:CTIC) exchanged 12.82 million shares and the average volume remained 2.49 million shares. The stock escalated 22.64 % and closed the session at $1.95. The beta of the stock remained 5.29 and the EPS of the stock remained -0.93. The shares outstanding of the stock remained 114.78 million. Cell Therapeutics, Inc. (CTI) is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic ways to treats cancer. The Company is concentrating its efforts on treatments that target blood-related cancers where there is an unmet medical need.
For How Long CTIC will fight for Profitability? Read This Trend Analysis report
Chinanet Online Holdings Inc (NASDAQ:CNET) gained volume of 139,545 shares, while the average volume remained 18,865shares. The stock advanced 20.53% and finished the session at $0.699. The EPS of the stock remained 0.13. The one month of the stock was 9.58% and three month trend remained positive 27.11 %.ChinaNet Online Holdings, Inc., formerly Emazing Interactive, Inc. is a holding company that conducts its primary businesses through its subsidiaries and operating companies. The Company’s services were founded on Internet and advertising technologies that include, preparing and publishing media enabled advertising and marketing campaigns for clients on the Internet, mobile phone, television and other valued added communication channels, hosting mini-sites with online messaging and consulting functionalities, generating sales leads and providing online management tools to help small and medium enterprise (SMEs) manage the expansion of their sales networks.
For How Long CNET Gloss will Attract Investors? Find out via this report
About:Best Stock on Demand
Beststocksondemand.com is an exciting online financial terminal where stock readers, traders and investors as well as market analysts can come to discover new opportunities, ideas, situations and news. Beststocksondemand.com goal is finding the most Undervalued or should we say Value Stocks or the Next Emerging Growth Stock that might be unnoticed by Wallstreet. Beststocksondemand.com is constantly searching for exceptional investment situations that can profit both investors and traders in order to grow their gains on a well balanced portfolio.
Beststocksondemand.com is also a well-respected marketing and research firm that mainly focuses on Best Stocks on Demand, Micro-Cap Stocks and Small Cap Stocks. Beststocksondemand.com uses its strategic corporate communication services to increase investor awareness of your company. We can support developing, emerging growth and deep-rooted companies in their marketing therefore creating a more dominant and operative investor alertness.
The assembled information disseminated by Beststocksondemand.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Beststocksondemand.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
Please read Our Full Disclaimer at: http://www.beststocksondemand.com/disclaimer.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)